US Broker Ratings

Disc Medicine, Inc. (IRON) Stock Analysis: Exploring a 62% Upside Potential as Biotech Innovates in Hematology

Disc Medicine, Inc. (NASDAQ: IRON) is garnering significant attention within the biotechnology sector, particularly amongst investors focused on innovative healthcare solutions. As a clinical-stage biopharmaceutical company, Disc Medicine is pioneering..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Uncovering a 22% Upside with Strong Revenue Growth

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector with its innovative approach to treating hemolytic anemias and a promising pipeline of therapies. For investors seeking opportunities..

Artivion, Inc. (AORT) Stock Analysis: Navigating Growth in the Medical Device Sector

Artivion, Inc. (AORT), a key player in the healthcare sector, specifically within the medical devices industry, is garnering attention from investors with its dynamic growth trajectory and innovative product offerings...

Evotec SE (EVO) Stock Analysis: Unlocking a Potential 61% Upside Amidst Strategic Collaborations

For investors seeking opportunities in the healthcare sector, Evotec SE (NASDAQ: EVO), a prominent player in the drug discovery and development industry, presents an intriguing proposition. With its focus on..

Denali Therapeutics Inc. (DNLI) Investor Outlook: Unpacking the 136% Potential Upside

Denali Therapeutics Inc. (NASDAQ: DNLI), a biotechnology firm entrenched in the healthcare sector, has caught the attention of investors with its ambitious pipeline and substantial potential upside. Trading at $13.32,..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Exploring a 220% Potential Upside

Investors seeking opportunities in the biotechnology sector may want to take a closer look at ARS Pharmaceuticals, Inc. (NASDAQ: SPRY). This San Diego-based biopharmaceutical firm is pioneering solutions to treat..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Unveiling a 36.62% Potential Upside with Innovative Biotech Solutions

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a burgeoning player in the healthcare sector, is capturing significant investor attention due to its promising portfolio of therapeutic candidates targeting eye care and infectious..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Unveiling a Potential 163% Upside in the Biotechnology Sector

Dyne Therapeutics, Inc. (NASDAQ: DYN), a biotechnology firm based in Waltham, Massachusetts, has captured investor attention with its promising potential upside of 163.04%. As a clinical-stage company dedicated to developing..

Premier, Inc. (PINC) Stock Analysis: Evaluating the Healthcare Leader Amidst Revenue Decline

As the healthcare sector continues to evolve, Premier, Inc. (NASDAQ: PINC) stands out as a key player in health information services. Headquartered in Charlotte, North Carolina, Premier offers a dual-segment..

PROCEPT BioRobotics (PRCT) Investor Outlook: Navigating a 70% Potential Upside in the Healthcare Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is making waves in the healthcare sector with its innovative surgical robotics solutions. As a key player in the medical devices industry, the company has..

Mesoblast Limited (MESO): Investor Outlook Highlights 60% Potential Upside

For investors with an eye on the biotechnology sector, Mesoblast Limited (NASDAQ: MESO) offers an intriguing opportunity. The Australian-based company is making waves with its regenerative medicine products, and the..

Progyny, Inc. (PGNY) Stock Report: 27.65% Potential Upside Captures Investor Attention

Progyny, Inc. (NASDAQ: PGNY) is gaining traction in the healthcare sector with its innovative approach to fertility and family-building benefits. As a leader in healthcare plans, Progyny offers a compelling..

Select Medical Holdings Corpora (SEM): Investor Outlook on a 36.81% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.57 billion, the..

Astrana Health Inc. (ASTH): Investor Outlook Highlights 66% Potential Upside

Astrana Health Inc. (ASTH), a healthcare management company headquartered in Alhambra, California, is attracting significant investor attention due to its robust growth potential and an impressive analyst consensus. As the..

Omnicell, Inc. (OMCL) Stock Analysis: Potential 39% Upside Amidst Solid Growth in Healthcare Solutions

Omnicell, Inc. (NASDAQ: OMCL), a prominent player in the healthcare sector, stands out not just for its innovative solutions in medication management and adherence but also for its promising investment..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: 52% Potential Upside Sparks Interest

Investors are increasingly turning their attention to Scholar Rock Holding Corporation (SRRK), as a staggering 52.24% potential upside is catching the eye of those looking for promising opportunities in the..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring a 51% Upside Potential in the Innovative Genomics Sector

Twist Bioscience Corporation (NASDAQ: TWST), a key player in the rapidly evolving field of synthetic biology and genomics, presents an intriguing investment opportunity, particularly for those with an eye on..

Metsera, Inc. (MTSR) Stock Analysis: A Potential 32.51% Upside in the Booming Biotech Sector

Metsera, Inc. (NASDAQ: MTSR), a burgeoning name in the biotechnology sphere, is captivating investor attention with its groundbreaking approach to tackling obesity and related metabolic disorders. The New York-based clinical-stage..

SS Innovations International (SSII) Stock Analysis: A Closer Look at Its 121.80% Revenue Growth Amidst a Challenging Market

SS Innovations International, Inc. (SSII), a pioneering force in the surgical robotics sector, has garnered significant attention with its staggering 121.80% revenue growth. As a commercial-stage company based in Gurugram,..

Phreesia, Inc. (PHR) Stock Analysis: A 37% Potential Upside Amid Robust Revenue Growth

Phreesia, Inc. (NYSE: PHR) is making waves in the healthcare sector with its innovative SaaS-based software and payment platform, serving a diverse clientele across the United States and Canada. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds